Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT

Research output: Contribution to journalArticlepeer-review

Standard

Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT. / Earl, Helena; Hiller, Louise; Vallier, Anne-laure; Loi, Shrushma; Mcadam, Karen; Hughes-davies, Luke; Rea, Daniel; Howe, Donna; Raynes, Kerry; Higgins, Helen B; Wilcox, Maggie; Plummer, Chris; Mahler-araujo, Betania; Provenzano, Elena; Chhabra, Anita; Gasson, Sophie; Balmer, Claire; Abraham, Jean E; Caldas, Carlos; Hall, Peter; Shinkins, Bethany; Mccabe, Christopher; Hulme, Claire; Miles, David; Wardley, Andrew M; Cameron, David A; Dunn, Janet A.

In: Health Technology Assessment, Vol. 24, No. 40, 02.09.2020, p. 1-190.

Research output: Contribution to journalArticlepeer-review

Harvard

Earl, H, Hiller, L, Vallier, A, Loi, S, Mcadam, K, Hughes-davies, L, Rea, D, Howe, D, Raynes, K, Higgins, HB, Wilcox, M, Plummer, C, Mahler-araujo, B, Provenzano, E, Chhabra, A, Gasson, S, Balmer, C, Abraham, JE, Caldas, C, Hall, P, Shinkins, B, Mccabe, C, Hulme, C, Miles, D, Wardley, AM, Cameron, DA & Dunn, JA 2020, 'Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT', Health Technology Assessment, vol. 24, no. 40, pp. 1-190. https://doi.org/10.3310/hta24400

APA

Earl, H., Hiller, L., Vallier, A., Loi, S., Mcadam, K., Hughes-davies, L., Rea, D., Howe, D., Raynes, K., Higgins, H. B., Wilcox, M., Plummer, C., Mahler-araujo, B., Provenzano, E., Chhabra, A., Gasson, S., Balmer, C., Abraham, J. E., Caldas, C., ... Dunn, J. A. (2020). Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT. Health Technology Assessment, 24(40), 1-190. https://doi.org/10.3310/hta24400

Vancouver

Author

Earl, Helena ; Hiller, Louise ; Vallier, Anne-laure ; Loi, Shrushma ; Mcadam, Karen ; Hughes-davies, Luke ; Rea, Daniel ; Howe, Donna ; Raynes, Kerry ; Higgins, Helen B ; Wilcox, Maggie ; Plummer, Chris ; Mahler-araujo, Betania ; Provenzano, Elena ; Chhabra, Anita ; Gasson, Sophie ; Balmer, Claire ; Abraham, Jean E ; Caldas, Carlos ; Hall, Peter ; Shinkins, Bethany ; Mccabe, Christopher ; Hulme, Claire ; Miles, David ; Wardley, Andrew M ; Cameron, David A ; Dunn, Janet A. / Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT. In: Health Technology Assessment. 2020 ; Vol. 24, No. 40. pp. 1-190.

Bibtex

@article{0409db8aff9549e0b155d2e5c9bc1192,
title = "Six versus 12 months{\textquoteright} adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT",
author = "Helena Earl and Louise Hiller and Anne-laure Vallier and Shrushma Loi and Karen Mcadam and Luke Hughes-davies and Daniel Rea and Donna Howe and Kerry Raynes and Higgins, {Helen B} and Maggie Wilcox and Chris Plummer and Betania Mahler-araujo and Elena Provenzano and Anita Chhabra and Sophie Gasson and Claire Balmer and Abraham, {Jean E} and Carlos Caldas and Peter Hall and Bethany Shinkins and Christopher Mccabe and Claire Hulme and David Miles and Wardley, {Andrew M} and Cameron, {David A} and Dunn, {Janet A}",
year = "2020",
month = sep,
day = "2",
doi = "10.3310/hta24400",
language = "English",
volume = "24",
pages = "1--190",
journal = "Health Technology Assessment",
issn = "1366-5278",
publisher = "NIHR Health Technology Assessment Programme",
number = "40",

}

RIS

TY - JOUR

T1 - Six versus 12 months’ adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT

AU - Earl, Helena

AU - Hiller, Louise

AU - Vallier, Anne-laure

AU - Loi, Shrushma

AU - Mcadam, Karen

AU - Hughes-davies, Luke

AU - Rea, Daniel

AU - Howe, Donna

AU - Raynes, Kerry

AU - Higgins, Helen B

AU - Wilcox, Maggie

AU - Plummer, Chris

AU - Mahler-araujo, Betania

AU - Provenzano, Elena

AU - Chhabra, Anita

AU - Gasson, Sophie

AU - Balmer, Claire

AU - Abraham, Jean E

AU - Caldas, Carlos

AU - Hall, Peter

AU - Shinkins, Bethany

AU - Mccabe, Christopher

AU - Hulme, Claire

AU - Miles, David

AU - Wardley, Andrew M

AU - Cameron, David A

AU - Dunn, Janet A

PY - 2020/9/2

Y1 - 2020/9/2

U2 - 10.3310/hta24400

DO - 10.3310/hta24400

M3 - Article

VL - 24

SP - 1

EP - 190

JO - Health Technology Assessment

JF - Health Technology Assessment

SN - 1366-5278

IS - 40

ER -